Immune cell protein identified as potential target for rare liver cancer treatment

  • Post author:
  • Post category:uncategorized

Fibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The disease is caused by a single genetic mutation that creates a fusion protein.